Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307264911> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4307264911 endingPage "1685" @default.
- W4307264911 startingPage "1685" @default.
- W4307264911 abstract "Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor, and its prognosis is determined by the histological progression beyond the adenoma capsule. However, a preoperative evaluation of the histological progression remains challenging, and there is no consensus regarding treatment strategies for CXPA. Herein, we aimed to predict the histological progression preoperatively and develop an appropriate treatment strategy for CXPA. We retrospectively reviewed 22 patients with parotid gland CXPA recorded at our hospital. The clinicopathological characteristics were assessed, and survival analysis was performed. T3≤ or N+ were common in widely invasive CXPA (WICXPA) (p < 0.05). A tumor diameter > 40 mm and the N+ status were associated with poor prognosis considering overall survival (OS) and locoregional recurrence rate (LRC) (p < 0.05). Patients with facial nerve paralysis exhibited better OS and LRC than those without facial nerve paralysis. More than 90% of patients with WICXPA experienced distant metastases. Meanwhile, there were no cases of recurrence or death due to intracapsular and minimally invasive CXPA. A preoperative advanced T stage or N+ status was suspected as WICXPA. Tumors > 40 mm in size and N+ status necessitate high-intensity local treatment. Facial nerve invasion can be controlled by nerve resection. Postoperative systemic therapy could control distant metastases." @default.
- W4307264911 created "2022-10-31" @default.
- W4307264911 creator A5015720113 @default.
- W4307264911 creator A5016189987 @default.
- W4307264911 creator A5017557588 @default.
- W4307264911 creator A5026646725 @default.
- W4307264911 creator A5033715667 @default.
- W4307264911 creator A5043936285 @default.
- W4307264911 creator A5043976619 @default.
- W4307264911 creator A5061166011 @default.
- W4307264911 creator A5078425375 @default.
- W4307264911 date "2022-10-24" @default.
- W4307264911 modified "2023-10-14" @default.
- W4307264911 title "Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution" @default.
- W4307264911 cites W1977891261 @default.
- W4307264911 cites W1984099095 @default.
- W4307264911 cites W2003948667 @default.
- W4307264911 cites W2005760008 @default.
- W4307264911 cites W2049325430 @default.
- W4307264911 cites W2055559462 @default.
- W4307264911 cites W2058239954 @default.
- W4307264911 cites W2087422979 @default.
- W4307264911 cites W2089556772 @default.
- W4307264911 cites W2120136659 @default.
- W4307264911 cites W2120309085 @default.
- W4307264911 cites W2155007818 @default.
- W4307264911 cites W2160631797 @default.
- W4307264911 cites W2293008070 @default.
- W4307264911 cites W2593119424 @default.
- W4307264911 cites W2739541956 @default.
- W4307264911 cites W2775239209 @default.
- W4307264911 cites W2901312960 @default.
- W4307264911 cites W2969772063 @default.
- W4307264911 cites W3035446148 @default.
- W4307264911 cites W3092134393 @default.
- W4307264911 doi "https://doi.org/10.3390/life12111685" @default.
- W4307264911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36362841" @default.
- W4307264911 hasPublicationYear "2022" @default.
- W4307264911 type Work @default.
- W4307264911 citedByCount "0" @default.
- W4307264911 crossrefType "journal-article" @default.
- W4307264911 hasAuthorship W4307264911A5015720113 @default.
- W4307264911 hasAuthorship W4307264911A5016189987 @default.
- W4307264911 hasAuthorship W4307264911A5017557588 @default.
- W4307264911 hasAuthorship W4307264911A5026646725 @default.
- W4307264911 hasAuthorship W4307264911A5033715667 @default.
- W4307264911 hasAuthorship W4307264911A5043936285 @default.
- W4307264911 hasAuthorship W4307264911A5043976619 @default.
- W4307264911 hasAuthorship W4307264911A5061166011 @default.
- W4307264911 hasAuthorship W4307264911A5078425375 @default.
- W4307264911 hasBestOaLocation W43072649111 @default.
- W4307264911 hasConcept C141071460 @default.
- W4307264911 hasConcept C142724271 @default.
- W4307264911 hasConcept C2778937882 @default.
- W4307264911 hasConcept C2778987478 @default.
- W4307264911 hasConcept C2780395140 @default.
- W4307264911 hasConcept C2780885620 @default.
- W4307264911 hasConcept C2781437628 @default.
- W4307264911 hasConcept C71924100 @default.
- W4307264911 hasConceptScore W4307264911C141071460 @default.
- W4307264911 hasConceptScore W4307264911C142724271 @default.
- W4307264911 hasConceptScore W4307264911C2778937882 @default.
- W4307264911 hasConceptScore W4307264911C2778987478 @default.
- W4307264911 hasConceptScore W4307264911C2780395140 @default.
- W4307264911 hasConceptScore W4307264911C2780885620 @default.
- W4307264911 hasConceptScore W4307264911C2781437628 @default.
- W4307264911 hasConceptScore W4307264911C71924100 @default.
- W4307264911 hasIssue "11" @default.
- W4307264911 hasLocation W43072649111 @default.
- W4307264911 hasLocation W43072649112 @default.
- W4307264911 hasLocation W43072649113 @default.
- W4307264911 hasLocation W43072649114 @default.
- W4307264911 hasOpenAccess W4307264911 @default.
- W4307264911 hasPrimaryLocation W43072649111 @default.
- W4307264911 hasRelatedWork W1981317504 @default.
- W4307264911 hasRelatedWork W1993646227 @default.
- W4307264911 hasRelatedWork W2039015478 @default.
- W4307264911 hasRelatedWork W2131431186 @default.
- W4307264911 hasRelatedWork W2341283943 @default.
- W4307264911 hasRelatedWork W2410302380 @default.
- W4307264911 hasRelatedWork W2499139499 @default.
- W4307264911 hasRelatedWork W2884207078 @default.
- W4307264911 hasRelatedWork W2891365860 @default.
- W4307264911 hasRelatedWork W2972239448 @default.
- W4307264911 hasVolume "12" @default.
- W4307264911 isParatext "false" @default.
- W4307264911 isRetracted "false" @default.
- W4307264911 workType "article" @default.